QUOC V TRUONG MD NPI 1518922814

NPI Details

Quoc V Truong, MD is a hematology and oncology internal medicine in Wichita, KS with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Quoc V Truong, MD NPI is 1518922814. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:2001

The provider's business location address is:

818 N ENMPORIA
SUITE 403
WICHITA, KS
ZIP 67214-728
Phone: (316) 262-4467
Fax: (316) 262-0706

The NPI 1518922814 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Magnesium level (HCPCS:83735)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Unclassified drugs (HCPCS:J3490)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Folic acid level, serum (HCPCS:82746)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Injection of drug or substance into vein (HCPCS:96374)
• Vitamin d-3 level (HCPCS:82306)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Ct scan of chest with contrast (HCPCS:71260)

The enumeration date for this NPI number is 4/19/2006 and was last updated on 3/22/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.